S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.80 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.03 (-2.28%)
NIO   7.76 (+4.44%)
BABA   71.51 (-1.20%)
AMD   116.82 (-1.32%)
T   16.95 (-1.57%)
F   10.70 (+0.94%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.49%)
GE   119.82 (-0.34%)
DIS   91.51 (+0.79%)
AMC   6.79 (-3.28%)
PFE   28.81 (-1.00%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)

Innovative Eyewear Stock Price, News & Analysis (NASDAQ:LUCY)

$0.47
0.00 (0.00%)
(As of 12/6/2023 ET)
Compare
Today's Range
$0.44
$0.50
50-Day Range
$0.40
$0.58
52-Week Range
$0.36
$5.50
Volume
49,792 shs
Average Volume
1.11 million shs
Market Capitalization
$6.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.75

Innovative Eyewear MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
270.6% Upside
$1.75 Price Target
Short Interest
Healthy
0.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars


LUCY stock logo

About Innovative Eyewear Stock (NASDAQ:LUCY)

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

LUCY Stock Price History

LUCY Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Innovative Eyewear, Inc. (LUCY)
Why Innovative Eyewear Stock Is Soaring Today
See More Headlines
Receive LUCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovative Eyewear and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/13/2024

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LUCY
Fax
N/A
Employees
9
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.75
High Stock Price Target
$1.75
Low Stock Price Target
$1.75
Potential Upside/Downside
+270.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-5,680,000.00
Net Margins
-1,017.90%
Pretax Margin
-1,017.90%

Debt

Sales & Book Value

Annual Sales
$603,793.00
Book Value
$0.55 per share

Miscellaneous

Free Float
11,481,000
Market Cap
$6.10 million
Optionable
Not Optionable
Beta
0.53
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Harrison Reed Gross (Age 30)
    Co-Founder, CEO & Director
    Comp: $114.76k
  • Mr. Konrad Dabrowski (Age 39)
    Co-Founder & CFO
    Comp: $105.5k
  • Mr. David Eric Cohen (Age 50)
    Co-Founder & CTO
    Comp: $70.27k
  • Mr. Ekene Ofodile
    Senior VP Sales & Marketing














LUCY Stock Analysis - Frequently Asked Questions

Should I buy or sell Innovative Eyewear stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innovative Eyewear in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LUCY shares.
View LUCY analyst ratings
or view top-rated stocks.

What is Innovative Eyewear's stock price target for 2024?

1 equities research analysts have issued 1 year target prices for Innovative Eyewear's shares. Their LUCY share price targets range from $1.75 to $1.75. On average, they anticipate the company's stock price to reach $1.75 in the next year. This suggests a possible upside of 270.6% from the stock's current price.
View analysts price targets for LUCY
or view top-rated stocks among Wall Street analysts.

How have LUCY shares performed in 2023?

Innovative Eyewear's stock was trading at $1.37 at the start of the year. Since then, LUCY stock has decreased by 65.5% and is now trading at $0.4722.
View the best growth stocks for 2023 here
.

When is Innovative Eyewear's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our LUCY earnings forecast
.

When did Innovative Eyewear IPO?

(LUCY) raised $8 million in an initial public offering (IPO) on the week of August 15th 2022. The company issued 900,000 shares at a price of $7.50-$9.50 per share. Maxim Group served as the underwriter for the IPO.

How do I buy shares of Innovative Eyewear?

Shares of LUCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:LUCY) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -